|
Main
|
|
Note: This record shows only 24 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
22 August 2022 |
|
Main ID: |
NCT05211609 |
|
Date of registration:
|
17/12/2021 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Prevalence of High Plasmatic 3OMethyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency
DOPADEF |
|
Scientific title:
|
Prevalence of High Plasmatic 3-O-Methyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency (Aromatic L-Amino Acid Decarboxylase) |
|
Date of first enrolment:
|
May 20, 2022 |
|
Target sample size:
|
388 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT05211609 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Contact type:
|
|
|
Name:
|
Agathe ROUBERTIE, PH |
|
Address:
|
|
|
Telephone:
|
0467336343 |
|
Email:
|
a-roubertie@chu-montpellier.fr |
|
Affiliation:
|
|
|
|
Contact type:
|
|
|
Name:
|
Agathe ROUBERTIE, PH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
a-roubertie@chu-montpellier.fr |
| |
|
Key inclusion & exclusion criteria
|
|
Health Condition(s) or Problem(s) studied
|
|
Source(s) of Monetary Support
|
|
Results
|
| Results available: |
|
| URL: |
|
| URL of the protocol: |
|
| Date Posted: |
|
| Date of completion: |
|
| Date of first publication: |
|
| Results summary: |
|
| Baseline characteristics: |
|
| Adverse events: |
|
| Outcome measures: |
|
| IPD sharing plan: |
|
| IPD sharing description: |
|
|
|